Concepedia

Ramesh Balusu

RB

37

Publications

2.2K

Citations

27

H-Index

2004

Active since

Affiliations

University of Kansas Medical Center(Current)

The University of Kansas Cancer Center

Augusta University

University of Florida Health

Novartis (United States)

Ramesh Balusu is an author at University of Kansas Medical Center specializing in medicine, cell biology, and radiation oncology.

ORCID

Top concepts

Publications per year

2004–2024

37

Publications

37

Combined epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A and the histone deacetylase inhibitor panobinostat against human AML cells

Warren Fiskus, Yongchao Wang, Arun Sreekumar et al. · Blood · 2009 · 355 citations · Full text

Cotreatment with panobinostat and JAK2 inhibitor TG101209 attenuates JAK2V617F levels and signaling and exerts synergistic cytotoxic effects against human myeloproliferative neoplastic cells

Yongchao Wang, Warren Fiskus, Daniel G. Chong et al. · Blood · 2009 · 177 citations · Full text

Targeting levels or oligomerization of nucleophosmin 1 induces differentiation and loss of survival of human AML cells with mutant NPM1

Ramesh Balusu, Warren Fiskus, Rekha Rao et al. · Blood · 2011 · 134 citations · Full text

Leukemogenic nucleophosmin mutation disrupts the transcription factor hub that regulates granulomonocytic fates

Xiaorong Gu, Quteba Ebrahem, Reda Z. Mahfouz et al. · Journal of Clinical Investigation · 2018 · 116 citations · Full text

Combination of Pan-Histone Deacetylase Inhibitor and Autophagy Inhibitor Exerts Superior Efficacy against Triple-Negative Human Breast Cancer Cells

Rekha Rao, Ramesh Balusu, Warren Fiskus et al. · Molecular Cancer Therapeutics · 2012 · 105 citations · Full text

, , +16

Rows per page

1–5 of 37